$154.27▴ 9.93%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Moderna, Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days11 articles
3 bullish7 neutral1 bearish
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell?
Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026
Prediction: Moderna Stock Will Soar 100% by 2030
Stock Market Midday, Sept. 30: Markets Rise on Softer Inflation Data, Investors Await Micron Earnings